Congestive Heart Failure Clinical Trial
Official title:
Genetic Risk Assessment of Defibrillator Events: A Prospective Multicenter Observational Study
Arrhythmias remain a major health problem, causing at least 250,000 deaths annually in the
United States. Pharmacological treatments often do more harm than good, and device therapies
are limited by high cost and effects on quality of life. Ion channel mutations cause rare
inherited arrhythmopathies, but account for only a small fraction of patients with life-
threatening arrhythmias and sudden death. Most arrhythmias occur during myocardial ischemia,
following myocardial infarction, and in patients with poor left ventricular (LV) function of
any etiology. Aside from ejection fraction (EF), few clinically useful indicators to
stratify the risk of sudden death have been identified. The role of subtle difference in ion
channel expression and/or structure in predisposing patients to arrhythmias and modulating
the risk of sudden death is unknown.
In this study, we are prospectively testing whether polymorphisms in ion channels and ion
channel modifying genes are associated with arrhythmias in a population with internal
cardioverter-defibrillators (ICDs) and poor LV function. We will test the hypothesis that
functional polymorphisms in the coding sequences and promoter regions of cardiac genes (e.g.
ion channels, beta-adrenergic receptors) predispose individuals to arrhythmias and /or heart
failure progression.
We hope to identify genetic predictors for the common forms of sudden cardiac death. This
would allow the identification of a subpopulation of heart failure patients that would
benefit most from ICD placement.
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT04037436 -
Functional Exercise and Nutrition Education Program for Older Adults
|
N/A | |
Recruiting |
NCT04703842 -
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
|
Phase 1/Phase 2 | |
Terminated |
NCT05594940 -
Heart Failure Monitoring With a Portable Ultrasound Device With Artificial Intelligence Assisted Tools: A Multi-Phase Observational Feasibility Study
|
||
Recruiting |
NCT04982081 -
Treating Congestive HF With hiPSC-CMs Through Endocardial Injection
|
Phase 1 | |
Completed |
NCT04394754 -
Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure
|
N/A | |
Active, not recruiting |
NCT01385176 -
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
|
N/A | |
Not yet recruiting |
NCT05516290 -
Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure
|
||
Terminated |
NCT02788656 -
Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)
|
Phase 4 | |
Completed |
NCT02885636 -
Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
|
Phase 3 | |
Terminated |
NCT02205411 -
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
|
N/A | |
Completed |
NCT02252757 -
Assess Measurements of Wireless Cardiac Output Device
|
N/A | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Withdrawn |
NCT00346177 -
Stem Cell Study for Patients With Heart Failure
|
Phase 2 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Active, not recruiting |
NCT01058837 -
SCD-HeFT 10 Year Follow-up
|
N/A | |
Completed |
NCT00957541 -
Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device
|
Phase 2 |